The pharmaceutical manufacturer Valeant had a business model of cost-cutting, minimizing expenditures on research and delaying clinical trials. The model succeeded, as Valeant became one of the largest pharmaceutical companies in the world, with a market capitalization of $41 billion in 2014.

Required

What type of competitive strategy did Valeant employ? Is this strategy sustainable and ethical for a pharmaceutical company?